Pulmocide Limited: Pulmocide Raises $30 Million in Series B Financing

World News: . []

Pulmocide Raises 3630 Million in Series B Financing Funding to progress novel wholly-owned compounds for RSV and pulmonary Aspergillosis London UK 20 March 2017 Pulmocide Ltd the UK-based drug discovery company developing no vel com...

More news and information about Pulmocide Limited

Published By:

Thomson Reuters: 07:01 GMT Monday 20th March 2017

Published: .

Search for other references to "pulmocide" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2017. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Ground Floor Offices, Little Keep Gate, Barrack Road, Dorchester, Dorset DT1 1AH
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us
 

Advertising on SPi News: Information For Advertisers